We are live on ! Find out more
FA

Forefront Analytics Portfolio holdings

AUM $110M
1-Year Est. Return 18.54%
This Fund
S&P 500
This Quarter Est. Return
+2.78%
1 Year Est. Return
+18.54%
3 Year Est. Return
+33.55%
5 Year Est. Return
+24.76%
10 Year Est. Return
AUM
$235M
AUM Growth
+$4.45M
Cap. Flow
-$568K
Cap. Flow %
-0.24%
Top 10 Hldgs %
53.89%
Holding
74
New
11
Increased
24
Reduced
25
Closed
7

Sector Composition

Rank Sector Weight
1 Healthcare 0.9%
2 Financials 0.86%
3 Materials 0.47%
4 Technology 0.28%
5 Industrials 0.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVS icon
51
CVS Health
CVS
$137B
$226K 0.1%
2,967
-267
-8% -$19.4K
AGI icon
52
Alamos Gold
AGI
$11.9B
$223K 0.1%
+28,500
New +$229K
NEM icon
53
Newmont
NEM
$95.8B
$223K 0.1%
+3,700
New +$221K
HSIC icon
54
Henry Schein
HSIC
$10B
$217K 0.09%
3,135
-139
-4% -$9.4K
KGC icon
55
Kinross Gold
KGC
$27B
$213K 0.09%
+32,000
New +$222K
ESGD icon
56
iShares ESG Aware MSCI EAFE ETF
ESGD
$11.7B
$204K 0.09%
+2,687
New +$202K
B
57
Barrick Mining
B
$58.5B
$198K 0.08%
+10,000
New +$216K
DYAI icon
58
Dyadic International
DYAI
$45.9M
$161K 0.07%
29,210
+5,794
+25% +$32.1K
DVAX
59
DELISTED
Dynavax Technologies
DVAX
$121K 0.05%
12,290
-782
-6% -$6.45K
VRNA
60
DELISTED
Verona Pharma
VRNA
$118K 0.05%
+14,102
New +$117K
ORTX
61
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$118K 0.05%
1,611
-1,598
-50% -$114K
GERN icon
62
Geron
GERN
$924M
$113K 0.05%
70,898
+10,723
+18% +$19.1K
RVLP
63
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$99K 0.04%
30,118
+12,027
+66% +$49.5K
EIGR
64
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$97K 0.04%
+359
New +$113K
ATNX
65
DELISTED
Athenex, Inc. Common Stock
ATNX
$65K 0.03%
+765
New +$147K
ADAM
66
Adamas Trust
ADAM
$807M
$45K 0.02%
2,500
PEI
67
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
$19K 0.01%
667
AAPL icon
68
Apple
AAPL
$4.9T
-1,766
Closed -$235K
DHR icon
69
Danaher
DHR
$144B
-1,045
Closed -$206K
EMB icon
70
PUT
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.6B
-8,435
Closed -$978K
LYFT icon
71
Lyft
LYFT
$5.89B
-24,137
Closed -$1.19M
SNY icon
72
Sanofi
SNY
$107B
-5,191
Closed -$254K
VCLT icon
73
Vanguard Long-Term Corporate Bond ETF
VCLT
$8.99B
-9,021
Closed -$1M
VXRT
74
DELISTED
Vaxart
VXRT
-18,250
Closed -$106K

Similar funds

Forefront Analytics's Q1 2021 Portfolio in Review

As of Q1 2021, Forefront Analytics held 74 positions worth $235M, up 1.9% from $230M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Forefront Analytics's Q1 2021 filing shows 11 new, 24 increased, 25 reduced and 7 closed positions. Its largest new stake was Vanguard Short-Term Bond ETF: 36,470 shares worth $3M. The largest sale was Lyft, an estimated $1.19M.

By sector, the portfolio is most concentrated in Healthcare at 0.9% of assets, up from 0.87% a quarter earlier, followed by Financials and Materials.

  • Forefront Analytics's largest Q1 2021 buy was Vanguard Short-Term Bond ETF: 36,470 shares worth $3M.
  • Forefront Analytics added most to Invesco Senior Loan ETF in Q1 2021, an estimated $1.99M increase.
  • Forefront Analytics's biggest Q1 2021 reduction was Vanguard World Funds Extended Duration ETF, cutting an estimated $1.05M.
  • Forefront Analytics fully exited Lyft in Q1 2021, selling an estimated $1.19M.
  • Forefront Analytics's ten largest holdings make up 54% of its $235M portfolio in Q1 2021.
  • Forefront Analytics opened 11 new positions and closed 7 in Q1 2021.
  • Forefront Analytics's portfolio value rose 1.9% quarter-over-quarter to $235M.

Based on Forefront Analytics's 13F filing for Q1 2021, filed 13 May 2021.